The world of health care is abuzz about precision medicine. The approach, built on advances in gene research and data analytics, tailors treatment of disease to a person’s unique biochemical makeup. But there is a problem: its focus is on treating disease rather than preventing it. And according to Kevin Hrusovsky, there’s a better way forward – with precision health.
Hrusovsky – a biotech engineer, and president, chairman and CEO of Quanterix, a company leading the precision health movement with its biomarker technology – challenged Stern Strategy Group to strengthen his voice and spark more meaningful dialogue and action around precision health.